Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of artificial intelligence, which could save valuable NHS time and resources, as well as improve care for patients.
Arrivo targets major depressive disorder in females after early efficacy data – Pharmaceutical Technology
: SP-624 may treat depression in women by modulating the distinct female genetic profile. Credit: Prathankarnpap/Shutterstock Arrivo BioVentures’ SIRT6 activator SP-624 has been found to